Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
All content for Caris Molecular Minute Podcast Series is the property of Dr. Chadi Nabhan and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
Interview with Dr. Salma Jabbour: An In-depth Look at the PROSPECT Trial
Caris Molecular Minute Podcast Series
21 minutes 16 seconds
2 years ago
Interview with Dr. Salma Jabbour: An In-depth Look at the PROSPECT Trial
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute. Together they discuss a plenary presentation that was given at ASCO 2023 on rectal cancer titled, the PROSPECT (Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and TME) trial.
The PROSPECT trial attempts to challenge the current treatment paradigm by individualizing treatment through the use of radiotherapy selectively rather than reflexively. This is a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for the treatment of locally advanced rectal cancer (LARC).
For more information, please visit: www.CarisLifeSciences.com
Caris Molecular Minute Podcast Series
Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
